EMG-Health Podcast: Emerging Immunotherapies for Patients with Myelodysplastic Syndrome - European Medical Journal

EMG-Health Podcast: Emerging Immunotherapies for Patients with Myelodysplastic Syndrome

Bonus Episode | 18 MAY 2021

Emerging Immunotherapies for Patients with Myelodysplastic Syndrome

This episode, sponsored by Novartis, is a discussion around myelodysplastic syndrome (MDS). Dr Esther Natalie Oliva, Great Metropolitan Hospital BMM, Italy, and Dr David Valcárcel, Vall d’Hebron University Hospital, Spain, elucidate on data regarding immunotherapy for the treatment of patients living with MDS from the recent European School of Haematology (ESH) 7th Translational Research Conference.
Download MP3 (mp3, 28:54 mins)

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now